- Home
- App Analytics
- PsychNotes: Clinical Pkt Guide
- PsychNotes: Clinical Pkt Guide Vs. Columbia Psychiatry Pathways
PsychNotes: Clinical Pkt Guide vs Columbia Psychiatry Pathways Usage & Stats
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
A Davis’s Notes Title, Perfect wherever you are…in class, in clinical, and in any practice setting! This handy guide delivers quick access to need-to-know information on DSM-5 disorders and treatments, psychotropic drugs, documentation, and patient education. No other resource delivers as much information in a format that’s as easy to read, easy to access the content on your mobile device.
KEY FEATURES
* Coverage of documentation • psychiatric medications, restraints, and seclusion • DSM-5 disorders and treatments • and patient education and care
* Basic behavioral theories at a glance
* Key aspects of psychiatric and crisis interventions
* General mental status assessments and exams, with focused assessments for adult and geriatric populations, including mini-cognitive assessment instrument for dementia and rating scale for Lewy Body diseases
* Essential information on psychotropic drugs
* Client/family education tables, tips, and strategies
* Cultural considerations and assessment tool
NEW TO THIS EDITION
* Addresses important topics such as Telepsychiatry and Teletherapy and more importantly the pandemic and its effect on mental health, both on individuals as well as health care providers.
* Several new psychotropics — for tardive dyskinesia, PTSD, treatment-resistant depression, and also a new medication for schizophrenia.
* Crises that deal with Covid and PTSD as well as the military, and geriatrics in a clinical pocket companion.
* Multiaxial assessment, CAGE, self-administered patient health questionnaires 2 and 9, and many other assessment tools
* Clinical pearls throughout to provide practical on-the-spot advice
* UPDATED & REVISED! All content thoroughly reviewed, revised, and updated to incorporate the newest knowledge in the field, including new drugs and drug updates.
ISBN 13: 9781719645454
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $29.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): Maxine Papadakis, Stephen McPhee, Michael Rabow, Kenneth McQuaid
Publisher: The McGraw-Hill Companies, Inc.
- Apple App Store
- Free
- Medical
Store Rank
- -
Designed by expert psychiatrists from Columbia University and delivered via cutting-edge, interactive technology from avoMD, this evidence-based app provides a practical and easy-to-use treatment algorithm for major depression.
This app incorporates Columbia’s Accelerated Sequential Antidepressant Protocol (ASAP) © 2021 The Trustees of Columbia University in the City of New York. Complete with calculators to assess depression severity (PHQ-9 and Columbia Depression Scale), bipolar screening, and suicide risk assessment, this app puts all the information you need to treat depression at your fingertips. Also included are clinical pearls such as how to titrate antidepressants and manage common side effects.
A revamp of the STAR*D Trial published in 2006, ASAP recommends rapid titrations and follow-up with a focus on the 7 best-tolerated generic antidepressants, providing a quicker and easier way to treat depression.
Columbia Psychiatry Pathways is intended for use in outpatient settings by psychiatrists, primary care physicians, nurse practitioners, physician assistants, medical students, residents, and trainees as they treat patients with depression.
FEATURES:
- Designed by experts from Columbia University's Department of Psychiatry and delivered via avoMD's next-gen decision support technology
- Regularly updated to reflect the latest research, with external links to the evidence
- Provides clinical pearls for depression treatment, including a walkthrough of titration recommendations, management of common side effects, and more
- Covers the 7 essential meds you need to know to effectively treat outpatient depression
- Includes recommendations on managing DSM-5 depression and screening for bipolar disorder and suicide risk
- Measure symptom severity using built-in calculators for Patient Health Questionnaire-9 item (PHQ-9) and the Columbia Depression Scale
- Intended for outpatient settings to aid psychiatrists, primary care physicians, nurse practitioners, physician assistants, and trainees make real-time psychopharmacologic decisions
- Functions as a teaching and learning tool for program directors, residents, med
students, and other trainees
Ranked #3 in NIH funding and in the top 5 psychiatry hospitals in the country by US News, the Department of Psychiatry at Columbia University has been a preeminent academic psychiatry department for over 100 years. Columbia Psychiatry faculty have led the development of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and served as leaders in the field including the current National Institutes of Mental Health Director. The inventors of this clinical algorithm are J. John Mann, MD, co-director of Columbia’s Center for the Prevention and Treatment of depression and a leading researcher in the field of mood disorders, and Ravi N. Shah, MD, MBA, a pioneer in digital mental health and the department’s Chief Innovation Officer.
avoMD transforms clinical guidelines, pathways, and algorithms into interactive, next-gen decision support apps, made available as standalone mobile and web apps and via EHR integrations. Leading academic medical centers, urgent cares, and trainee programs are using avoMD to digitize their clinical content and put them in the hands of their providers or distribute them externally. In randomized control trials and usability studies, the software has been shown to save providers time while improving clinical accuracy. Current investors and supporters include Columbia University’s Lang Entrepreneurship Center, Mount Sinai Innovation Partners’ Elementa Labs, StartUp Health, and 500 Startups. The team is led by physicians and informaticians from Columbia, Harvard, and Yale.
Subscriptions ($19.99 / year) automatically renew unless auto-renew is turned off. Cancellations at least 24 hours prior to subscription renewal will not be charged. You can manage your subscription and auto-renewal from your Apple ID account settings after purchase.
- Apple App Store
- Free
- Medical
Store Rank
- -
PsychNotes: Clinical Pkt Guide vs. Columbia Psychiatry Pathways ranking comparison
Compare PsychNotes: Clinical Pkt Guide ranking trend in the past 28 days vs. Columbia Psychiatry Pathways
Rank
No Data Available
PsychNotes: Clinical Pkt Guide vs. Columbia Psychiatry Pathways ranking by country comparison
Compare PsychNotes: Clinical Pkt Guide ranking trend in the past 28 days vs. Columbia Psychiatry Pathways
No Data to Display
Compare to any site with our free trial
PsychNotes: Clinical Pkt Guide VS.
Columbia Psychiatry Pathways
December 17, 2024